VEVIX | VMVAX | VEVIX / VMVAX | |
Total Expense Ratio | 0.58 | 0.07 | 829% |
Annual Report Gross Expense Ratio | 0.58 | 0.07 | 829% |
Fund Existence | 15 years | 14 years | - |
Gain YTD | -2.334 | 0.049 | -4,764% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.1B | 29.9B | 57% |
Annual Yield % from dividends | 1.19 | 2.31 | 52% |
Returns for 1 year | -6.32 | 6.99 | -90% |
Returns for 3 years | 8.09 | 29.05 | 28% |
Returns for 5 years | 40.41 | 68.41 | 59% |
Returns for 10 years | 42.26 | 77.30 | 55% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FSMD | 40.62 | 0.19 | +0.47% |
Fidelity Small-Mid Multifactor ETF | |||
AFMC | 31.35 | 0.13 | +0.42% |
First Trust Active Factor Mid Cap ETF | |||
TLT | 86.65 | 0.15 | +0.17% |
iShares 20+ Year Treasury Bond ETF | |||
VLU | 187.75 | 0.25 | +0.13% |
SPDR® S&P 1500 Value Tilt ETF | |||
UMAR | 36.91 | 0.01 | +0.02% |
Innovator U.S. Equity Ultra BffrETF™-Mar |